INOVIOPossible readd on a retracement if we find support at retracement levels. Could break out of wedge structure and long way to find resistance on macro levels
INO trade ideas
INO Inovio Pharmaceuticals Options Ahead of EarningsAnalyzing the options chain and the chart patterns of INO Inovio Pharmaceuticals prior to the earnings report this week,
I would consider purchasing the 13usd strike price Calls with
an expiration date of 2024-5-17,
for a premium of approximately $0.25.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
$INO 50% upside potentialNASDAQ:INO had a streak of green weeks recently and currently is trading above a significant resistance at $11.96
- MACD weekly just turned positive
- Vortex index is positive
INO 1D 2 Month Larger TF shows continuation. Time/Space corrective until wave (B). Breakout of falling wedge finished. Retracement and continuation.
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
INO Bullish Deep CrabINO has completed a bottom formation IMO. I believe the bottom has come in a harmonic deep crab formation. I've highlighted the accumulation zone. This is high risk but also has the potential of being a 5 to 100x bagger. Good Luck!
💊 INO SELL THE BREAK 📉INO has broken out of a larger degree correction and continues to make smaller degree flags in the bearish direction.
Stick to your trading rules!
Inovio timeCovid is here to stay!
Data from the WHO will be good. Time to buy and hold. Let the shorts
INO 1W 168% from $1.92Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
inovio will hit rock bottom and will make you rich, unless, Unless the company ends bad . .
i wouldnt know as i only read charts and follow trend .
i say that ino will hit the 47-50c mark , but hey , take a look at its highest high : $180
ok im not that positive or healthy to live another 30 years or so ,... but it might be a stock worth following .
what you think ?
Bullish on Inovio!!!!!! If you think covid is over? Think again!
It will rise like never before and Ino will be the next Moderna!
Be ready and be safe
Inovio is turning. INO? Wave A or something else. It is unclear what is forming in this picture exactly, but you can see the momentum shift in the candlesticks. Volatility and parabolism have both turned negative to add fuel to the fire.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
INO approaching extreme support zone 🍿 there might be a little pain on this one, but i doubt it goes back into the .6-1.5 extreme support range..
when the market rallies again I expect big things for this one, maybe it will dip a little more short term, but im bullish long term if support holds.
INO Inverse H&S Trend Reversal This chart displays an inverse H&S, touches of the LS can be seen on 1.618, and the head touching on 2.618.
We know this is a trend reversal pattern due to the MA currently acting as a support, contrary to the previous resistance line during the formation of the H&S.
This is a weekly chart.
Buy is warranted.
INO - New Variant SA Covid / Aids DerivINO - A Gates-sponsored entity.
One to keep an eye upon.
it is a Trading Instrument for the Jumbos when it
gets in gear, look out above.
____________________________________________
A heads-up in advance.
INO LongDaily: Trendline Break
Weekly: At Support Zone
Entry 7
Stop 5.5
Target 16
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
Inovio Pharmaceuticals - AccumulationAccording to the Hawk Liquidation Theory, expecting over 10,000% on INO in the coming years.
INOSell at 9.58, Breakout of triangle. A breakout above the smiley face is another good sign for more upwards movement. Short-term gains.
INO What You're Thinking...INO finally broke back above the 786 fib line. Before the last bout of selling, you'll see this level was an area of support for the former penny stock. Now, thanks to some added excitement from delta news (the variant not the airline), INO shares are popping. They also jumped back above the 786 fib. Now the question is, will it rest the 618 fib like it tried to a few weeks ago?
"Inovio Pharmaceuticals Inc. (NASDAQ: INO) has steadily climbed for the better part of the last 3 months thanks to recent pipeline progress. In June, the company had expanded its partnership with Advaccine Biopharmaceuticals Suzhou to conduct a Phase 3 segment of a trial called INNOVATE. The goal is to evaluate the safety and efficacy of the company’s INO-4800 in COVID patients. The treatment was already shown to be well tolerated and immunogenic in tested age groups in a Phase 2 study.
This month Inovio announced that it and Advaccine received a regulatory allowance for 2 heterologous prime-boost clinical trials in China using INO-4800. “VID-19. If approved, we believe INO-4800 will be well-positioned to serve the vaccine needs of the global community as both a primary and a booster vaccine due to its tolerability, balanced cross-reactive immune responses, and strong thermostability profile that does not require cold or ultra-cold-chain transport,” said Dr. J. Joseph Kim, President, and CEO of INOVIO."
Quote Source & Read more on INO: Former Penny Stocks To Watch After Merck’s ( MRK ) Latest FDA Win
